Search

Author/Creator Abbou, S.

1. ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT. (October 2022)

Authors:
d'Hautefeuille, C.; Abbou, S.; El-Gourari-Miaz, L.; Lambilliotte, A.; Renard, C.; Landman-Parker, J.; Gourdon, S.; Metayer, L.; Leblanc, T.; Pacquement, H.; Rabian, F.; Verschuur, A.; Brasme, J.; Millot, F.; Pagnier, A.; Buchbinder, N.; Rorhlich, P.; Minard-Colin, V.; Brugières, L.; Ducassou, S.
Journal:
Leukemia research
Issue:
Volume 121(2022)Supplement
Page Start:
S68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines. (16th November 2016)

Authors:
Seror, E.; Donadieu, J.; Pacquement, H.; Abbou, S.; Lambilliotte, A.; Schell, M.; Curtillet, C.; Gandemer, V.; Pasquet, M.; Aladjidi, N.; Lutz, P.; Schmitt, C.; Deville, A.; Minckes, O.; Vanier, J P.; Armari-Alla, C.; Thomas, C.; Gorde-Grosjean, S.; Millot, F.; Blouin, P.
Journal:
Pediatric hematology and oncology
Issue:
Volume 33:Number 7/8(2016)
Page Start:
423
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗